AZD7798 Safety, Tolerability, and Pharmacokinetics after a single ascending and repeat dose administrations to healthy subjects, and patients with Crohn's disease

Trial Identifier:	D9690C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT05452304
Start Date:	July 2022
Primary Completion Date:	September 2024
Study Completion Date:	September 2024
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Harrow, GB, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.